No Data
No Data
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate
H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120
Praxis Precision Med Price Target Maintained With a $120.00/Share by HC Wainwright & Co.
Promising Pipeline and Strategic Developments Position Praxis Precision Medicines for Market Expansion
Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $305
Express News | Praxis Precision Medicines Inc : Jefferies Raises Target Price to $305 From $144
No Data
BarfBag : Check out $Pagaya Technologies (PGY.US)$ solid AH